SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Electrocardiographic abnormalities in patients with cardiomyopathies.

Aimo, A; Milandri, A; Barison, A; Pezzato, A; Morfino, P; Vergaro, G; Merlo, M; Argirò, A; Olivotto, I; Emdin, M; et al. Aimo, A; Milandri, A; Barison, A; Pezzato, A; Morfino, P; Vergaro, G; Merlo, M; Argirò, A; Olivotto, I; Emdin, M; Finocchiaro, G; Sinagra, G; Elliott, P; Rapezzi, C (2024) Electrocardiographic abnormalities in patients with cardiomyopathies. Heart Fail Rev, 29 (1). pp. 151-164. ISSN 1573-7322 https://doi.org/10.1007/s10741-023-10358-7
SGUL Authors: Finocchiaro, Gherardo

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview
[img] Microsoft Word (.docx) (Supplementary file 1) Published Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

Abnormalities in impulse generation and transmission are among the first signs of cardiac remodeling in cardiomyopathies. Accordingly, 12-lead electrocardiogram (ECG) of patients with cardiomyopathies may show multiple abnormalities. Some findings are suggestive of specific disorders, such as the discrepancy between QRS voltages and left ventricular (LV) mass for cardiac amyloidosis or the inverted T waves in the right precordial leads for arrhythmogenic cardiomyopathy. Other findings are less sensitive and/or specific, but may orient toward a specific diagnosis in a patient with a specific phenotype, such as an increased LV wall thickness or a dilated LV. A "cardiomyopathy-oriented" mindset to ECG reading is important to detect the possible signs of an underlying cardiomyopathy and to interpret correctly the meaning of these alterations, which differs in patients with cardiomyopathies or other conditions.

Item Type: Article
Additional Information: © The Author(s) 2023 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Amyloidosis, Cardiomyopathy, ECG, Electrocardiogram, Hypertrophic cardiomyopathy, ECG, Electrocardiogram, Cardiomyopathy, Hypertrophic cardiomyopathy, Amyloidosis, 1102 Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Heart Fail Rev
ISSN: 1573-7322
Language: eng
Dates:
DateEvent
January 2024Published
17 October 2023Published Online
3 October 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 37848591
Web of Science ID: WOS:001084485100001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115903
Publisher's version: https://doi.org/10.1007/s10741-023-10358-7

Actions (login required)

Edit Item Edit Item